Veru Inc (VERU)
1.47
0.00 (0.00%)
USD |
NASDAQ |
May 15, 16:00
1.47
0.00 (0.00%)
After-Hours: 16:06
Veru Free Cash Flow: -39.87M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -39.87M |
| December 31, 2023 | -59.88M |
| September 30, 2023 | -88.68M |
| June 30, 2023 | -100.00M |
| March 31, 2023 | -95.66M |
| December 31, 2022 | -74.10M |
| September 30, 2022 | -48.24M |
| June 30, 2022 | -28.24M |
| March 31, 2022 | -27.10M |
| December 31, 2021 | -25.56M |
| September 30, 2021 | -15.95M |
| June 30, 2021 | -15.29M |
| March 31, 2021 | 1.004M |
| December 31, 2020 | 1.148M |
| September 30, 2020 | -2.036M |
| June 30, 2020 | -2.651M |
| March 31, 2020 | -6.573M |
| December 31, 2019 | -6.620M |
| September 30, 2019 | -5.594M |
| June 30, 2019 | -7.423M |
| March 31, 2019 | -11.42M |
| December 31, 2018 | -13.40M |
| September 30, 2018 | -11.60M |
| June 30, 2018 | -8.216M |
| March 31, 2018 | -2.192M |
| Date | Value |
|---|---|
| December 31, 2017 | 0.0438M |
| September 30, 2017 | 0.8494M |
| June 30, 2017 | -0.5396M |
| March 31, 2017 | -1.550M |
| December 31, 2016 | -0.1862M |
| September 30, 2016 | -1.721M |
| June 30, 2016 | 0.586M |
| March 31, 2016 | -0.1423M |
| December 31, 2015 | -0.8958M |
| September 30, 2015 | -1.684M |
| June 30, 2015 | -0.9913M |
| March 31, 2015 | -0.3701M |
| December 31, 2014 | 1.246M |
| September 30, 2014 | 3.568M |
| June 30, 2014 | 0.4178M |
| March 31, 2014 | 7.841M |
| December 31, 2013 | 11.64M |
| September 30, 2013 | 11.49M |
| June 30, 2013 | 13.58M |
| March 31, 2013 | 9.592M |
| December 31, 2012 | 8.820M |
| September 30, 2012 | 9.638M |
| June 30, 2012 | 10.87M |
| March 31, 2012 | 9.187M |
| December 31, 2011 | 6.605M |
Free Cash Flow Range, Past 5 Years
-100.00M
Minimum
Jun 2023
1.148M
Maximum
Dec 2020
-32.37M
Average
-20.75M
Median
Free Cash Flow Benchmarks
| EyePoint Pharmaceuticals Inc | -16.65M |
| INVO Bioscience Inc | -5.200M |
| Bio-Path Holdings Inc | -11.54M |
| Aileron Therapeutics Inc | -19.81M |
| ProKidney Corp | -132.89M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -5.65M |
| Cash from Investing (Quarterly) | -0.0407M |
| Cash from Financing (Quarterly) | -0.1503M |
| Free Cash Flow Per Share (Quarterly) | -0.0389 |
| Free Cash Flow to Equity (Quarterly) | -5.708M |
| Free Cash Flow to Firm (Quarterly) | -5.543M |
| Free Cash Flow Yield | -25.50% |